Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 63 |
| List of Tables | 55 | 9 |
| List of Figures | 64 | 1 |
| Introduction | 65 | 1 |
| Global Markets Direct Report Coverage | 65 | 1 |
| Ovarian Cancer Overview | 66 | 1 |
| Therapeutics Development | 67 | 2 |
| Pipeline Products for Ovarian Cancer Overview | 67 | 1 |
| Pipeline Products for Ovarian Cancer Comparative Analysis | 68 | 1 |
| Ovarian Cancer Therapeutics under Development by Companies | 69 | 22 |
| Ovarian Cancer Therapeutics under Investigation by Universities/Institutes | 91 | 3 |
| Ovarian Cancer Pipeline Products Glance | 94 | 4 |
| Late Stage Products | 94 | 1 |
| Clinical Stage Products | 95 | 1 |
| Early Stage Products | 96 | 1 |
| Unknown Stage Products | 97 | 1 |
| Ovarian Cancer Products under Development by Companies | 98 | 29 |
| Ovarian Cancer Products under Investigation by Universities/Institutes | 127 | 4 |
| Ovarian Cancer Companies Involved in Therapeutics Development | 131 | 271 |
| 3-V Biosciences, Inc. | 131 | 1 |
| 4SC AG | 132 | 1 |
| AB Science SA | 133 | 1 |
| AbbVie Inc. | 134 | 1 |
| AbGenomics International, Inc. | 135 | 1 |
| Acetylon Pharmaceuticals, Inc. | 136 | 1 |
| Adaptimmune Therapeutics Plc | 137 | 1 |
| Adgero Biopharmaceuticals, Inc. | 138 | 1 |
| Aduro BioTech, Inc. | 139 | 1 |
| Advanced Accelerator Applications S.A. | 140 | 1 |
| Advantagene, Inc. | 141 | 1 |
| Advaxis, Inc. | 142 | 1 |
| Advenchen Laboratories, LLC | 143 | 1 |
| Aeterna Zentaris Inc. | 144 | 1 |
| Alchemia Limited | 145 | 1 |
| Alethia Biotherapeutics Inc. | 146 | 1 |
| Almac Discovery Limited | 147 | 1 |
| Alpha Cancer Technologies Inc. | 148 | 1 |
| Alteogen Inc. | 149 | 1 |
| Ambrx, Inc. | 150 | 1 |
| Amgen Inc. | 151 | 1 |
| Anavex Life Sciences Corp. | 152 | 1 |
| ANP Technologies, Inc. | 153 | 1 |
| Antoxis Limited | 154 | 1 |
| Apac Biotech Pvt Ltd | 155 | 1 |
| Aphios Corporation | 156 | 1 |
| Aposense Ltd. | 157 | 1 |
| Aprea AB | 158 | 1 |
| arGEN-X BV | 159 | 1 |
| Armour Therapeutics Inc. | 160 | 1 |
| Arno Therapeutics, Inc. | 161 | 1 |
| Arog Pharmaceuticals, Inc. | 162 | 1 |
| ArQule, Inc. | 163 | 1 |
| Arrien Pharmaceuticals, LLC | 164 | 1 |
| Arvinas, Inc. | 165 | 1 |
| Ascentage Pharma Group Corporation, Ltd. | 166 | 1 |
| Astellas Pharma Inc. | 167 | 1 |
| Astex Pharmaceuticals, Inc. | 168 | 1 |
| AstraZeneca Plc | 169 | 1 |
| Atara Biotherapeutics, Inc. | 170 | 1 |
| ATLAB Pharma SAS | 171 | 1 |
| AVEO Pharmaceuticals, Inc. | 172 | 1 |
| Avipep Pty Ltd | 173 | 1 |
| Azaya Therapeutics, Inc. | 174 | 1 |
| Basilea Pharmaceutica AG | 175 | 1 |
| Bavarian Nordic A/S | 176 | 1 |
| Bayer AG | 177 | 1 |
| BeiGene, Ltd. | 178 | 1 |
| BioCancell Ltd | 179 | 1 |
| BioMoti Limited | 180 | 1 |
| BioNTech AG | 181 | 1 |
| BioNumerik Pharmaceuticals, Inc. | 182 | 1 |
| Bioo Therapeutics | 183 | 1 |
| Biscayne Pharmaceuticals, Inc. | 184 | 1 |
| Boehringer Ingelheim GmbH | 185 | 1 |
| Boston Biomedical, Inc. | 186 | 1 |
| Bristol-Myers Squibb Company | 187 | 1 |
| Calithera Biosciences, Inc. | 188 | 1 |
| CASI Pharmaceuticals Inc. | 189 | 1 |
| Cavion LLC | 190 | 1 |
| Cellceutix Corporation | 191 | 1 |
| Celldex Therapeutics, Inc. | 192 | 1 |
| Cellectar Biosciences, Inc. | 193 | 1 |
| Cellular Biomedicine Group, Inc. | 194 | 1 |
| Celon Pharma Sp. z o.o. | 195 | 1 |
| Celprogen, Inc. | 196 | 1 |
| Celsion Corporation | 197 | 1 |
| Celyad SA | 198 | 1 |
| Ceronco Biosciences | 199 | 1 |
| CerRx, Inc. | 200 | 1 |
| Cerulean Pharma, Inc. | 201 | 1 |
| Chikujee Therapeutics | 202 | 1 |
| Chipscreen Biosciences Ltd | 203 | 1 |
| Clovis Oncology, Inc. | 204 | 1 |
| CohBar, Inc. | 205 | 1 |
| Coherus BioSciences, Inc. | 206 | 1 |
| Commence Bio, Inc. | 207 | 1 |
| Compliment Corporation | 208 | 1 |
| Corcept Therapeutics Incorporated | 209 | 1 |
| Critical Outcome Technologies Inc. | 210 | 1 |
| CritiTech, Inc. | 211 | 1 |
| CTI BioPharma Corp. | 212 | 1 |
| Cyclacel Pharmaceuticals, Inc. | 213 | 1 |
| CytRx Corporation | 214 | 1 |
| CZ BioMed Corp | 215 | 1 |
| Debiopharm International SA | 216 | 1 |
| Deciphera Pharmaceuticals, LLC | 217 | 1 |
| DEKK-TEC, Inc. | 218 | 1 |
| DelMar Pharmaceuticals, Inc. | 219 | 1 |
| Dr. Reddy's Laboratories Limited | 220 | 1 |
| EirGenix Inc. | 221 | 1 |
| Eisai Co., Ltd. | 222 | 1 |
| Eli Lilly and Company | 223 | 1 |
| Endocyte, Inc. | 224 | 1 |
| EntreChem, S.L. | 225 | 1 |
| Epigen Biosciences, Inc. | 226 | 1 |
| Esperance Pharmaceuticals, Inc. | 227 | 1 |
| Exelixis, Inc. | 228 | 1 |
| F. Hoffmann-La Roche Ltd. | 229 | 1 |
| Fate Therapeutics, Inc. | 230 | 1 |
| Forty Seven Inc. | 231 | 1 |
| Fujifilm Corporation | 232 | 1 |
| Galena Biopharma, Inc. | 233 | 1 |
| GamaMabs Pharma S.A. | 234 | 1 |
| Ganymed Pharmaceuticals AG | 235 | 1 |
| Gene Techno Science Co., Ltd. | 236 | 1 |
| Genelux Corporation | 237 | 1 |
| Genentech, Inc. | 238 | 1 |
| Generex Biotechnology Corporation | 239 | 1 |
| Genisphere Inc. | 240 | 1 |
| Genmab A/S | 241 | 1 |
| Genor BioPharma Co., Ltd. | 242 | 1 |
| Gero Corp | 243 | 1 |
| Gilead Sciences, Inc. | 244 | 1 |
| GlaxoSmithKline Plc | 245 | 1 |
| Glenmark Pharmaceuticals Ltd. | 246 | 1 |
| GlycoNex Inc. | 247 | 1 |
| Glycotope GmbH | 248 | 1 |
| GP Pharm, S.A. | 249 | 1 |
| Gradalis Inc. | 250 | 1 |
| GW Pharmaceuticals Plc | 251 | 1 |
| Halozyme Therapeutics, Inc. | 252 | 1 |
| HEC Pharm Co., Ltd. | 253 | 1 |
| Hemispherx Biopharma, Inc. | 254 | 1 |
| Horizon Pharma Plc | 255 | 1 |
| Ideaya Biosciences Inc | 256 | 1 |
| Ignyta, Inc. | 257 | 1 |
| IMMD Inc. | 258 | 1 |
| Immune Design Corp. | 259 | 1 |
| Immune Pharmaceuticals Inc. | 260 | 1 |
| ImmunoFrontier, Inc. | 261 | 1 |
| ImmunoGen, Inc. | 262 | 1 |
| Immunomedics, Inc. | 263 | 1 |
| Immunovaccine, Inc. | 264 | 1 |
| Incyte Corporation | 265 | 1 |
| Inflection Biosciences Limited | 266 | 1 |
| Innate Immunotherapeutics Ltd | 267 | 1 |
| Innate Pharma S.A. | 268 | 1 |
| Inovio Pharmaceuticals, Inc. | 269 | 1 |
| INSYS Therapeutics, Inc. | 270 | 1 |
| Inventiva | 271 | 1 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 272 | 1 |
| Johnson &Johnson | 273 | 1 |
| Juno Therapeutics Inc. | 274 | 1 |
| Karyopharm Therapeutics, Inc. | 275 | 1 |
| Komipharm International Co., Ltd. | 276 | 1 |
| Kyowa Hakko Kirin Co., Ltd. | 277 | 1 |
| Laboratoire HRA Pharma | 278 | 1 |
| Lee's Pharmaceutical Holdings Limited | 279 | 1 |
| LegoChem Biosciences, Inc | 280 | 1 |
| Lymphocyte Activation Technologies, S.A. | 281 | 1 |
| Mabion SA | 282 | 1 |
| MabVax Therapeutics Holdings, Inc. | 283 | 1 |
| MacroGenics, Inc. | 284 | 1 |
| Mateon Therapeutics Inc | 285 | 1 |
| MaxiVAX SA | 286 | 1 |
| Mebiopharm Co., Ltd. | 287 | 1 |
| Medestea Research &Production S.p.A. | 288 | 1 |
| MediaPharma s.r.l. | 289 | 1 |
| MedImmune, LLC | 290 | 1 |
| Medivation, Inc. | 291 | 1 |
| MEI Pharma, Inc. | 292 | 1 |
| Merck &Co., Inc. | 293 | 1 |
| Merck KGaA | 294 | 1 |
| Mersana Therapeutics, Inc. | 295 | 1 |
| Merus B.V. | 296 | 1 |
| Midatech Pharma Plc | 297 | 1 |
| Millennium Pharmaceuticals, Inc. | 298 | 1 |
| Minerva Biotechnologies Corporation | 299 | 1 |
| Molecular Partners AG | 300 | 1 |
| MolMed S.p.A. | 301 | 1 |
| Momenta Pharmaceuticals, Inc. | 302 | 1 |
| Monopar Therapeutics LLC | 303 | 1 |
| Morphotek, Inc. | 304 | 1 |
| Mundipharma International Ltd | 305 | 1 |
| Mycenax Biotech Inc. | 306 | 1 |
| Natco Pharma Limited | 307 | 1 |
| Nektar Therapeutics | 308 | 1 |
| Nemucore Medical Innovations, Inc. | 309 | 1 |
| Neovacs SA | 310 | 1 |
| Nerviano Medical Sciences S.r.l. | 311 | 1 |
| Neurimmune Holding AG | 312 | 1 |
| Northwest Biotherapeutics, Inc. | 313 | 1 |
| Novartis AG | 314 | 1 |
| NovaTarg Therapeutics, Inc | 315 | 1 |
| Noviga Research AB | 316 | 1 |
| NuCana BioMed Limited | 317 | 1 |
| Oasmia Pharmaceutical AB | 318 | 1 |
| OBI Pharma, Inc. | 319 | 1 |
| Omeros Corporation | 320 | 1 |
| Omnitura Therapeutics Inc. | 321 | 1 |
| OncBioMune Pharmaceuticals Inc. | 322 | 1 |
| Oncobiologics, Inc. | 323 | 1 |
| Oncodesign SA | 324 | 1 |
| OncoHoldings, Inc. | 325 | 1 |
| Oncolix, Inc. | 326 | 1 |
| Oncolytics Biotech Inc. | 327 | 1 |
| OncoMed Pharmaceuticals, Inc. | 328 | 1 |
| Oncopeptides AB | 329 | 1 |
| OncoTartis, Inc. | 330 | 1 |
| Oncternal Therapeutics, Inc. | 331 | 1 |
| Ono Pharmaceutical Co., Ltd. | 332 | 1 |
| Optimum Therapeutics, LLC | 333 | 1 |
| ORCA Therapeutics B.V. | 334 | 1 |
| OSE Immunotherapeutics | 335 | 1 |
| Otsuka Holdings Co., Ltd. | 336 | 1 |
| Oxford BioMedica Plc | 337 | 1 |
| Pangaea Biotech, S.L. | 338 | 1 |
| Panther Biotechnology, Inc. | 339 | 1 |
| PDS Biotechnology Corporation | 340 | 1 |
| PEP-Therapy SAS | 341 | 1 |
| Pfizer Inc. | 342 | 1 |
| Pharma Mar, S.A. | 343 | 1 |
| Pharmacyclics, Inc. | 344 | 1 |
| PharmAust Limited | 345 | 1 |
| Pharmicell Co., Ltd. | 346 | 1 |
| Polaris Pharmaceuticals, Inc. | 347 | 1 |
| Precision Biologics, Inc. | 348 | 1 |
| Prima BioMed Ltd. | 349 | 1 |
| Progen Pharmaceuticals Limited | 350 | 1 |
| PsiOxus Therapeutics Limited | 351 | 1 |
| Puma Biotechnology, Inc. | 352 | 1 |
| Quest PharmaTech Inc. | 353 | 1 |
| Recepta Biopharma S.A. | 354 | 1 |
| Rexahn Pharmaceuticals, Inc. | 355 | 1 |
| Rgenix, Inc. | 356 | 1 |
| Richter Gedeon Nyrt. | 357 | 1 |
| Rigontec GmbH | 358 | 1 |
| Rosetta Genomics, Ltd. | 359 | 1 |
| Sanofi | 360 | 1 |
| Sanofi Pasteur SA | 361 | 1 |